Tradestie Institutional Equity Comparison Engine

LEXX vs SRZN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Options & Structure while LEXX counters with relative strength in Momentum & Technical. Fundamentally, LEXX trades at N/M Forward P/E with -3862.9% operating margin (-88.5% YoY revenue) versus SRZN at N/M Forward P/E and -485.4% operating margin (+408.6% YoY). In options structure, LEXX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LEXX N/M vs SRZN N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin -3862.9% vs -485.4% ยท YoY -88.5% vs +408.6%
Momentum & Technical Winner LEXX
1Y +300.9% vs +166.7% ยท 52W Pos 29% vs 79%
Options & Structure Winner SRZN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (5th %ile IV)
LEXX NASDAQ
Lexaria Bioscience Corp. Common Stock
Pharmaceutical Preparations
$4.41
-0.68% 1D
Market Cap $9.4M
1M Return +54.2%
1Y Return +300.91%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$32.32
+2.25% 1D
Market Cap $602.5M
1M Return +37.88%
1Y Return +166.67%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 5.0 Fund 32.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LEXX +300.91% SRZN +166.67% Spread: +134.24 pp (LEXX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LEXX Revenue SRZN Revenue LEXX Op. Margin SRZN Op. Margin Margin Edge
FY2018 $0M N/A -1525.4% N/A LEXX
FY2019 $0M N/A -1868.0% N/A LEXX
FY2020 $0M N/A -1062.2% N/A LEXX
FY2021 $0M N/A -786.8% N/A LEXX
FY2022 $0M $10M -2591.7% -354.7% SRZN
FY2023 $0M N/A -2888.5% N/A LEXX
FY2024 $0M $10M -1239.2% -239.7% SRZN
FY2025 $0M $0M -1683.0% -1210.6% SRZN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LEXX (0) vs SRZN (7)
Institutional Metric LEXX SRZN Criterion Row Winner
Market Capitalization Scale $9.4M $602.5M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -88.5% +408.6% Higher Growth SRZN
Operating Margin (TTM) Profitability -3862.9% -485.4% Higher Margin SRZN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -162.8% -62.8% Higher ROE SRZN
52-Week Range Position Momentum 29% ($0โ€“$14) 79% ($12โ€“$38) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 11.09ฮฒ ยท 92% Vol 1.21ฮฒ ยท 62% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 33.3 / 100 (SELL) 34.3 / 100 (SELL) Higher Composite SRZN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LEXX vs SRZN Buy Guide
LEXX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LEXX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRZN CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LEXX nor SRZN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.